EXHIBIT 32.1
CERTIFICATION OF CEO PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of MIV Therapeutics, Inc. (the "Company")
on Form 10-K/A for the year ending May 31, 2007 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), Alan P. Lindsay, as
President and Chief Executive Officer of the Company, certifies, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, to the best of his knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.
/s/ Alan P. Lindsay
- -------------------
Alan P. Lindsay
Chairman and Chief Executive Officer
December 3, 2007